Cingulate Inc Stock Exchange News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cingulate inc stock exchange. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cingulate Inc Stock Exchange Today - Breaking & Trending Today

Cingulate to Present at 13th Annual LD Micro Invitational

KANSAS CITY, Kan., May 25, 2023 Cingulate Inc. , a biopharmaceutical company utilizing its proprietary Precision Timed Release™ drug delivery platform technology to build and advance a. | May 25, 2023 ....

Kansas City , United States , Thomas Dalton , Shanej Schaffer , Los Angeles , Matt Kreps , Cingulate Inc , Darrow Associates Investor Relations , Precision Timed Release , Luxe Sunset Boulevard Hotel , Public Relations , Cingulate Inc Stock Exchange , Press Release , Dvance Cing Us17248w1053 ,

Cingulate : Market Offering Agreement - Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

. | May 5, 2023 ....

United States , Shanej Schaffer , Hc Wainwright Co , Securities Exchange , Opinion Of Lowenstein Sandler , Cingulate Inc , Nasdaq Stock Market , Consent Of Lowenstein Sandler , Securities Exchange Act , Zip Code , General Instruction , Securities Act , Exchange Act , Nasdaq Capital Market , Common Stock , Sales Agreement , Lowenstein Sandler , Page Interactive Data File , Cingulate Inc Stock Exchange , Press Release , Urrent Cing Us17248w1053 ,

Cingulate Announces Successful Transfer of CTx-1301 (dexmethylphenidate) Proprietary PTR™ Manufacturing Processes to Societal CDMO

Scalable Supply of CTx-1301 Ready to be Produced with Cingulate on Track to Meet Previously Announced Clinical Timelines for Phase 3 Trial ProgramKANSAS CITY, Kan., May 03, 2023 Cingulate Inc. ,. | May 3, 2023 ....

United States , Kansas City , San Diego , Melyssa Weible , Matt Kreps , Thomas Dalton , Shanej Schaffer , David Enloe , Darrow Associates , Platform Technology , Elixir Health Public Relations , Master Services Agreement , Trial Program , Science To Society , Exchange Commission , Cingulate Inc , Societal Cdmo Inc , Securities Exchange , Company Phase , Scalable Supply , Meet Previously Announced Clinical Timelines , Precision Timed Release , New Drug Application , Hyperactivity Disorder , Erosion Barrier Layer , Investigational New Drug ,

Cingulate : Announces Successful Transfer of CTx-1301 (dexmethylphenidate) - Form 8-K

Cingulate Announces Successful Transfer of CTx-1301

Proprietary PTR™ Manufacturing Processes to Societal CDMO

Scalable Supply of CTx-1301 Ready to be. | May 3, 2023 ....

United States , Kansas City , San Diego , David Enloe , Shanej Schaffer , Matt Kreps , Melyssa Weible , Thomas Dalton , Exchange Commission , Platform Technology , Securities Exchange , Elixir Health Public Relations , Trial Program , Societal Cdmo Inc , Science To Society , Master Services Agreement , Company Phase , Cingulate Inc , Darrow Associates , Cingulateannounces Successful Transfer , Manufacturing Processes , Meet Previously Announced Clinical Timelines , Precision Timed Release , New Drug Application , Hyperactivity Disorder , Erosion Barrier Layer ,

Cingulate to Participate in Benzinga All Live Access Event

KANSAS CITY, Kan., April 14, 2023 Cingulate Inc. , a biopharmaceutical company utilizing its proprietary Precision Timed Release™ drug delivery platform technology to build and advance a. | April 14, 2023 ....

United States , Kansas City , Thomas Dalton , Melyssa Weible , Matt Kreps , Benzinga Youtube , Shanej Schaffer , Cingulate Inc , Elixir Health Public Relations , Darrow Associates , Precision Timed Release , Benzinga All Access , Tuesday April , Hyperactivity Disorder , Public Relations , Cingulate Inc Stock Exchange , Press Release , Dvance Cing Us17248w1053 ,